SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-170318
Filing Date
2008-08-07
Accepted
2008-08-07 17:26:52
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 332609
2 LICENSE AGREEMENT AS OF APRIL 2, 2008 dex101.htm EX-10.1 88099
3 PLAN AMENDMENT TO 2004 STOCK INCENTIVE PLAN dex102.htm EX-10.2 9507
4 CERTIFICATION BY PRESIDENT AND CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8771
5 CERTIFICATION BY PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER dex312.htm EX-31.2 8987
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3152
  Complete submission text file 0001193125-08-170318.txt   452564
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 08999693
SIC: 2836 Biological Products, (No Diagnostic Substances)